Clin2
NCT07693426Possibly a fitRecruiting

Study of efsubaglutide alfa for obese teenagers

Adolescence Obesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests an injection called efsubaglutide alfa to help obese teenagers lose weight. It requires following diet and exercise advice for at least 3 months before starting.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
36 people
Ages
12 years to 17 years
Study type
Interventional

Who can take part

  • You are 12 to 17 years old
  • You are obese based on Chinese standards for children
  • You have tried diet and exercise for at least 3 months without much weight loss
  • You agree to continue diet and exercise during the study
  • You do not have certain health problems or take weight-affecting medicines

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07114419Recruiting· Phase 2
New weekly injection for weight loss in overweight or obesity

This study tests a new weekly injection, efsubaglutide alfa (a GLP-1 drug), for helping people with overweight or obesity lose weight. It is for people who have not been able to lose weight with diet and exercise alone and do not have other serious health conditions.

Brookvale
NCT07518121Not yet recruiting· Phase 1
Safety study of efsubaglutide in healthy Brazilian adults

This is an early-stage safety study testing a new medication called efsubaglutide in healthy adults. Researchers want to make sure it is safe and understand how the body processes it.

Valinhos, São Paulo
NCT07302802Recruiting
Semaglutide for weight loss in teens with genetic obesity

This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.

Paris
NCT06852391Recruiting· Phase 4
Weight loss program with or without semaglutide for teens with obesity

This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.

Hamilton, Ontario
NCT07021937Not yet recruiting· Phase 3
Brain changes and weight loss medication for teens and adults with obesity

This study tests whether a medication that helps with weight loss, called a GLP-1 agonist, can also change how the brain works. It is for teenagers (12-18) and adults (30-45) with obesity.

Aurora, Colorado
NCT06977438Not yet recruiting· Phase 4
GLP-1 medication and lifestyle program for teen weight management

This trial tests a GLP-1 medication (a drug that helps control appetite and blood sugar) combined with a lifestyle program for teens with severe obesity. The goal is to see if this approach can improve overall health and well-being.

Minneapolis, Minnesota

Hear when a new Adolescence Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.